Yoichi Okumura has a master degrees of both law and pharmacy. He worked for Takeda Pharmaceutical Company, Ltd. for more than 30 years in its functions of Intellectual Property and Business Development such as product licenses and M&A. During his Business Development career, he drove several product licensing deals as a negotiation leader and worked on some M&A activities including some in Cambridge, MA. Within capacity of his last Takeda carrier as a Global Head of IP, he played several leader roles of global industry IP associations. Soon after leaving Takeda, he became a CEO of the bio-venture Scohia Pharma, Inc. until mid 2022.